Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
July 8, 2026
[Clinical significance of comprehensive genomic profiling in hematopoietic failure]
Satoru Aoyama
Plos One
|
March 23, 2013
Thioredoxin-interacting protein gene expression via MondoA is rapidly and transiently suppressed during inflammatory responses
Yasuyoshi Kanari, Yuki Sato, Satoru Aoyama, et al.
British Journal of Cancer
|
December 22, 2025
Exploratory analysis of gene aberrations and chemotherapy response: findings from a real-world database in Japan
Naoya Ishibashi, Takashi Kamatani, Satoru Aoyama, et al.
Journal of Medical Virology
|
April 28, 2015
Hypermutation in the E2 gene of human papillomavirus type 16 in cervical intraepithelial neoplasia
Iwao Kukimoto, Seiichiro Mori, Satoru Aoyama, et al.
Cancer
|
May 30, 2026
A real-world data analysis of the impact of clonal hematopoiesis of indeterminate potential on therapeutic efficacy and adverse events of immune checkpoint inhibitors
Takamasa Fujita, Naoya Ishibashi, Satoru Aoyama, et al.
International Journal of Molecular Medicine
|
February 4, 2022
A novel chimeric antigen receptor (CAR) system using an exogenous protease, in which activation of T cells is controlled by expression patterns of cell‑surface proteins on target cells
Satoru Aoyama, Shunichiro Yasuda, Huixin Li, et al.
Journal of Virology
|
November 15, 2013
APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation
Zhe Wang, Kousho Wakae, Kouichi Kitamura, et al.
IJU Case Reports
|
September 3, 2024
A case of double-negative prostate cancer with <i>BRCA2</i> mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab
Hiroki Tanaka, Soichiro Yoshida, Satoru Aoyama, et al.
Cancer Genetics
|
August 21, 2025
A novel fumarate hydratase frameshift mutation in lung adenocarcinoma: A case report
Haruko Nakagawa, Satoru Aoyama, Junko Yokobori, et al.
Expert Opinion on Drug Safety
|
December 17, 2024
Identification of risk factors for gastrointestinal immune-related adverse events associated with immune check point inhibitors
Ryo Morikawa, Kentaro Nitta, Shuntaro Yasuda, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
July 8, 2026
[Clinical significance of comprehensive genomic profiling in hematopoietic failure]
Satoru Aoyama
Plos One
|
March 23, 2013
Thioredoxin-interacting protein gene expression via MondoA is rapidly and transiently suppressed during inflammatory responses
Yasuyoshi Kanari, Yuki Sato, Satoru Aoyama, et al.
British Journal of Cancer
|
December 22, 2025
Exploratory analysis of gene aberrations and chemotherapy response: findings from a real-world database in Japan
Naoya Ishibashi, Takashi Kamatani, Satoru Aoyama, et al.
Journal of Medical Virology
|
April 28, 2015
Hypermutation in the E2 gene of human papillomavirus type 16 in cervical intraepithelial neoplasia
Iwao Kukimoto, Seiichiro Mori, Satoru Aoyama, et al.
Cancer
|
May 30, 2026
A real-world data analysis of the impact of clonal hematopoiesis of indeterminate potential on therapeutic efficacy and adverse events of immune checkpoint inhibitors
Takamasa Fujita, Naoya Ishibashi, Satoru Aoyama, et al.
International Journal of Molecular Medicine
|
February 4, 2022
A novel chimeric antigen receptor (CAR) system using an exogenous protease, in which activation of T cells is controlled by expression patterns of cell‑surface proteins on target cells
Satoru Aoyama, Shunichiro Yasuda, Huixin Li, et al.
Journal of Virology
|
November 15, 2013
APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation
Zhe Wang, Kousho Wakae, Kouichi Kitamura, et al.
IJU Case Reports
|
September 3, 2024
A case of double-negative prostate cancer with <i>BRCA2</i> mutation and high tumor mutation burden treated sequentially with olaparib and pembrolizumab
Hiroki Tanaka, Soichiro Yoshida, Satoru Aoyama, et al.
Cancer Genetics
|
August 21, 2025
A novel fumarate hydratase frameshift mutation in lung adenocarcinoma: A case report
Haruko Nakagawa, Satoru Aoyama, Junko Yokobori, et al.
Expert Opinion on Drug Safety
|
December 17, 2024
Identification of risk factors for gastrointestinal immune-related adverse events associated with immune check point inhibitors
Ryo Morikawa, Kentaro Nitta, Shuntaro Yasuda, et al.
Page
of 2